

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.11923191 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.50823116 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.50823116 |
| 4 | leukocyte aggregation (GO:0070486) | 4.09167008 |
| 5 | cellular response to zinc ion (GO:0071294) | 4.08548920 |
| 6 | cytidine metabolic process (GO:0046087) | 3.96052151 |
| 7 | cytidine catabolic process (GO:0006216) | 3.96052151 |
| 8 | cytidine deamination (GO:0009972) | 3.96052151 |
| 9 | response to peptidoglycan (GO:0032494) | 3.95280591 |
| 10 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.92719538 |
| 11 | sequestering of actin monomers (GO:0042989) | 3.88489827 |
| 12 | immunoglobulin mediated immune response (GO:0016064) | 3.88100232 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.85602971 |
| 14 | respiratory burst (GO:0045730) | 3.78361779 |
| 15 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.75609349 |
| 16 | neutrophil activation (GO:0042119) | 3.74704317 |
| 17 | granulocyte activation (GO:0036230) | 3.71496512 |
| 18 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.65716750 |
| 19 | positive regulation of B cell differentiation (GO:0045579) | 3.44547346 |
| 20 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.42514998 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.36143647 |
| 22 | positive regulation of mast cell activation (GO:0033005) | 3.36046700 |
| 23 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.33534205 |
| 24 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.33534205 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 3.31859176 |
| 26 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.29488346 |
| 27 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.22713169 |
| 28 | positive regulation of interferon-alpha production (GO:0032727) | 3.21591913 |
| 29 | type I interferon signaling pathway (GO:0060337) | 3.21321882 |
| 30 | cellular response to type I interferon (GO:0071357) | 3.21321882 |
| 31 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.20320687 |
| 32 | response to type I interferon (GO:0034340) | 3.19174300 |
| 33 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.18439622 |
| 34 | positive regulation of antigen processing and presentation (GO:0002579) | 3.17067861 |
| 35 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.15668994 |
| 36 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.15659003 |
| 37 | cellular extravasation (GO:0045123) | 3.15434590 |
| 38 | actin nucleation (GO:0045010) | 3.11275875 |
| 39 | B cell mediated immunity (GO:0019724) | 3.10616242 |
| 40 | positive regulation of mast cell degranulation (GO:0043306) | 3.05066780 |
| 41 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.05066780 |
| 42 | regulation of interferon-alpha production (GO:0032647) | 3.05057798 |
| 43 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.04153750 |
| 44 | leukocyte cell-cell adhesion (GO:0007159) | 3.02399289 |
| 45 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.02109121 |
| 46 | regulation of RIG-I signaling pathway (GO:0039535) | 2.97509744 |
| 47 | positive thymic T cell selection (GO:0045059) | 2.97359788 |
| 48 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.97256619 |
| 49 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.95986687 |
| 50 | positive regulation of interferon-beta production (GO:0032728) | 2.94198242 |
| 51 | NIK/NF-kappaB signaling (GO:0038061) | 2.93111494 |
| 52 | cellular response to interleukin-15 (GO:0071350) | 2.92912462 |
| 53 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.92732622 |
| 54 | defense response to protozoan (GO:0042832) | 2.92477822 |
| 55 | negative T cell selection (GO:0043383) | 2.91176119 |
| 56 | positive regulation of protein homooligomerization (GO:0032464) | 2.89619273 |
| 57 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.88406762 |
| 58 | positive regulation by symbiont of host defense response (GO:0052509) | 2.87898056 |
| 59 | modulation by symbiont of host defense response (GO:0052031) | 2.87898056 |
| 60 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.87898056 |
| 61 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.87898056 |
| 62 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.87898056 |
| 63 | modulation by symbiont of host immune response (GO:0052553) | 2.87898056 |
| 64 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.87610209 |
| 65 | natural killer cell mediated immunity (GO:0002228) | 2.87610209 |
| 66 | regulation of mast cell degranulation (GO:0043304) | 2.87296061 |
| 67 | regulation of mast cell activation (GO:0033003) | 2.86962923 |
| 68 | negative thymic T cell selection (GO:0045060) | 2.86389672 |
| 69 | response to interleukin-15 (GO:0070672) | 2.84950700 |
| 70 | macrophage activation involved in immune response (GO:0002281) | 2.84894454 |
| 71 | response to interferon-beta (GO:0035456) | 2.84649813 |
| 72 | regulation of activation of Janus kinase activity (GO:0010533) | 2.84311529 |
| 73 | regulation of T cell tolerance induction (GO:0002664) | 2.84112414 |
| 74 | regulation of cellular extravasation (GO:0002691) | 2.83363966 |
| 75 | response to protozoan (GO:0001562) | 2.81733123 |
| 76 | regulation of antigen processing and presentation (GO:0002577) | 2.81621016 |
| 77 | myeloid dendritic cell activation (GO:0001773) | 2.81208797 |
| 78 | cellular response to interferon-beta (GO:0035458) | 2.77959476 |
| 79 | leukocyte mediated cytotoxicity (GO:0001909) | 2.76733182 |
| 80 | detection of other organism (GO:0098543) | 2.75856038 |
| 81 | lipoxygenase pathway (GO:0019372) | 2.75525368 |
| 82 | T cell migration (GO:0072678) | 2.73554536 |
| 83 | negative regulation of interleukin-12 production (GO:0032695) | 2.73368826 |
| 84 | regulation of B cell differentiation (GO:0045577) | 2.72844033 |
| 85 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.72048240 |
| 86 | myeloid cell activation involved in immune response (GO:0002275) | 2.70976718 |
| 87 | T-helper 1 type immune response (GO:0042088) | 2.70570034 |
| 88 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.69935429 |
| 89 | myeloid dendritic cell differentiation (GO:0043011) | 2.69771666 |
| 90 | regulation of regulatory T cell differentiation (GO:0045589) | 2.69275112 |
| 91 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.68235323 |
| 92 | regulation of integrin activation (GO:0033623) | 2.67042693 |
| 93 | negative regulation of viral genome replication (GO:0045071) | 2.66780904 |
| 94 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.66372638 |
| 95 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.66216633 |
| 96 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.65277758 |
| 97 | leukocyte degranulation (GO:0043299) | 2.65079683 |
| 98 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.65049228 |
| 99 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.65001814 |
| 100 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.64953063 |
| 101 | superoxide anion generation (GO:0042554) | 2.64222282 |
| 102 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.62639280 |
| 103 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.62639280 |
| 104 | B cell receptor signaling pathway (GO:0050853) | 2.62612171 |
| 105 | DNA deamination (GO:0045006) | 2.62479156 |
| 106 | regulation of tolerance induction (GO:0002643) | 2.62155470 |
| 107 | reactive oxygen species biosynthetic process (GO:1903409) | 2.61035661 |
| 108 | negative regulation of phagocytosis (GO:0050765) | 2.60598987 |
| 109 | detection of bacterium (GO:0016045) | 2.60316027 |
| 110 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.60199812 |
| 111 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.59731172 |
| 112 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.59615841 |
| 113 | positive regulation of macrophage differentiation (GO:0045651) | 2.58938153 |
| 114 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.58528302 |
| 115 | regulation of mononuclear cell migration (GO:0071675) | 2.58286223 |
| 116 | regulation of response to interferon-gamma (GO:0060330) | 2.56565675 |
| 117 | regulation of superoxide anion generation (GO:0032928) | 2.56380756 |
| 118 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.56276316 |
| 119 | response to muramyl dipeptide (GO:0032495) | 2.55969273 |
| 120 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.55915488 |
| 121 | angiotensin maturation (GO:0002003) | 2.55342871 |
| 122 | positive regulation of isotype switching (GO:0045830) | 2.55313557 |
| 123 | T cell costimulation (GO:0031295) | 2.54488648 |
| 124 | dendritic cell chemotaxis (GO:0002407) | 2.54408789 |
| 125 | thymic T cell selection (GO:0045061) | 2.53215651 |
| 126 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.52306374 |
| 127 | positive regulation of lamellipodium assembly (GO:0010592) | 2.52093912 |
| 128 | regulation of podosome assembly (GO:0071801) | 2.50676917 |
| 129 | endosome to pigment granule transport (GO:0043485) | 2.50472876 |
| 130 | endosome to melanosome transport (GO:0035646) | 2.50472876 |
| 131 | lymphocyte costimulation (GO:0031294) | 2.50466136 |
| 132 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.50352826 |
| 133 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.50023970 |
| 134 | response to host immune response (GO:0052572) | 2.50023970 |
| 135 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.49927084 |
| 136 | positive regulation of type 2 immune response (GO:0002830) | 2.49899298 |
| 137 | positive regulation of interleukin-17 production (GO:0032740) | 2.49261581 |
| 138 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.49104725 |
| 139 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.48753482 |
| 140 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.45421067 |
| 141 | tolerance induction (GO:0002507) | 2.45345073 |
| 142 | negative regulation of innate immune response (GO:0045824) | 2.44942501 |
| 143 | T cell selection (GO:0045058) | 2.44279561 |
| 144 | mast cell activation (GO:0045576) | 2.44213569 |
| 145 | detection of external biotic stimulus (GO:0098581) | 2.42195145 |
| 146 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.42093051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.15754158 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.81672852 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.66643157 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.39729309 |
| 5 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.91686406 |
| 6 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.78598903 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.66591124 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.66250721 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.60384546 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.60206833 |
| 11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.54598972 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.49687598 |
| 13 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.41678219 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.35368223 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.34828217 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.34237467 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.28632777 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.27434597 |
| 19 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.21394336 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11424407 |
| 21 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95787080 |
| 22 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.95055200 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.91043116 |
| 24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.90099737 |
| 25 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.76547549 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.74248072 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.71762700 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.70474144 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68156312 |
| 30 | MYB_26560356_Chip-Seq_TH2_Human | 1.67716972 |
| 31 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.67609535 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.67080314 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.66047628 |
| 34 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.65454692 |
| 35 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.62805893 |
| 36 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.57870755 |
| 37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.55089514 |
| 38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54015228 |
| 39 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.51184659 |
| 40 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46527813 |
| 41 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.46489887 |
| 42 | MYB_26560356_Chip-Seq_TH1_Human | 1.44501287 |
| 43 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43753760 |
| 44 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.42039950 |
| 45 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.40936174 |
| 46 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40782464 |
| 47 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.39674651 |
| 48 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36359526 |
| 49 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.33735299 |
| 50 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32215795 |
| 51 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.31548638 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29032829 |
| 53 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.28913954 |
| 54 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.28849227 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28339183 |
| 56 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27507208 |
| 57 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.26782805 |
| 58 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26400880 |
| 59 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26165130 |
| 60 | UTX_26944678_Chip-Seq_JUKART_Human | 1.26138223 |
| 61 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25888659 |
| 62 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.25426584 |
| 63 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.23154782 |
| 64 | MAF_26560356_Chip-Seq_TH2_Human | 1.22478225 |
| 65 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21997167 |
| 66 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21655673 |
| 67 | SPI1_23127762_ChIP-Seq_K562_Human | 1.18710511 |
| 68 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.17707405 |
| 69 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.16811058 |
| 70 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16737915 |
| 71 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.16307031 |
| 72 | MYC_22102868_ChIP-Seq_BL_Human | 1.15735663 |
| 73 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.13963221 |
| 74 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.13917128 |
| 75 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.13842143 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12817195 |
| 77 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11757872 |
| 78 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.11460093 |
| 79 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11314654 |
| 80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09871727 |
| 81 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.09777382 |
| 82 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.09460651 |
| 83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06942173 |
| 84 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05283216 |
| 85 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.05278007 |
| 86 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.04680923 |
| 87 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.04275610 |
| 88 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.03995553 |
| 89 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.03522726 |
| 90 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.03498538 |
| 91 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.03199959 |
| 92 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.02182503 |
| 93 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.01822332 |
| 94 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.00973847 |
| 95 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.00944037 |
| 96 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.00657301 |
| 97 | P300_27268052_Chip-Seq_Bcells_Human | 1.00382193 |
| 98 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.00342053 |
| 99 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.00279177 |
| 100 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98895879 |
| 101 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.97115191 |
| 102 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96700238 |
| 103 | P68_20966046_ChIP-Seq_HELA_Human | 0.96447125 |
| 104 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95991437 |
| 105 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.95266026 |
| 106 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.94727783 |
| 107 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94328077 |
| 108 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.94163524 |
| 109 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.94152756 |
| 110 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94120473 |
| 111 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.93511211 |
| 112 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.93299426 |
| 113 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.93072250 |
| 114 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92601598 |
| 115 | * SA1_27219007_Chip-Seq_Bcells_Human | 0.92056449 |
| 116 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.91856850 |
| 117 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.90852310 |
| 118 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.89145379 |
| 119 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 0.86560259 |
| 120 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.86446609 |
| 121 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85439449 |
| 122 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.84589096 |
| 123 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.83296493 |
| 124 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.82830354 |
| 125 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.82652385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.17993948 |
| 2 | MP0009785_altered_susceptibility_to | 3.60251910 |
| 3 | MP0003436_decreased_susceptibility_to | 3.52183187 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.36194986 |
| 5 | MP0005671_abnormal_response_to | 3.22731999 |
| 6 | MP0000685_abnormal_immune_system | 3.18130405 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.86751406 |
| 8 | MP0005025_abnormal_response_to | 2.80411178 |
| 9 | MP0006082_CNS_inflammation | 2.72722423 |
| 10 | MP0003724_increased_susceptibility_to | 2.68864163 |
| 11 | MP0002419_abnormal_innate_immunity | 2.68342881 |
| 12 | MP0001790_abnormal_immune_system | 2.66195538 |
| 13 | MP0005387_immune_system_phenotype | 2.66195538 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.49499494 |
| 15 | MP0001800_abnormal_humoral_immune | 2.49351701 |
| 16 | MP0002723_abnormal_immune_serum | 2.40665629 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 2.39236936 |
| 18 | MP0001819_abnormal_immune_cell | 2.32531982 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.29969129 |
| 20 | MP0009278_abnormal_bone_marrow | 2.28076938 |
| 21 | MP0005058_abnormal_lysosome_morphology | 2.26670469 |
| 22 | MP0005397_hematopoietic_system_phenotyp | 2.24192040 |
| 23 | MP0001545_abnormal_hematopoietic_system | 2.24192040 |
| 24 | MP0009333_abnormal_splenocyte_physiolog | 2.21969294 |
| 25 | MP0002405_respiratory_system_inflammati | 2.20053019 |
| 26 | MP0005360_urolithiasis | 2.16766230 |
| 27 | MP0005464_abnormal_platelet_physiology | 2.03788736 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.99757771 |
| 29 | MP0001845_abnormal_inflammatory_respons | 1.88416475 |
| 30 | MP0001853_heart_inflammation | 1.87875430 |
| 31 | MP0002398_abnormal_bone_marrow | 1.84733541 |
| 32 | MP0003303_peritoneal_inflammation | 1.81698457 |
| 33 | MP0000716_abnormal_immune_system | 1.80648871 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.76472585 |
| 35 | MP0003763_abnormal_thymus_physiology | 1.74505679 |
| 36 | MP0004510_myositis | 1.73418607 |
| 37 | MP0002006_tumorigenesis | 1.72336578 |
| 38 | MP0004947_skin_inflammation | 1.71566208 |
| 39 | MP0000858_altered_metastatic_potential | 1.69182903 |
| 40 | MP0002166_altered_tumor_susceptibility | 1.66025993 |
| 41 | MP0005310_abnormal_salivary_gland | 1.65261712 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.56766863 |
| 43 | MP0009764_decreased_sensitivity_to | 1.55333028 |
| 44 | MP0003448_altered_tumor_morphology | 1.52843455 |
| 45 | MP0002429_abnormal_blood_cell | 1.52801386 |
| 46 | MP0000343_altered_response_to | 1.52769796 |
| 47 | MP0002722_abnormal_immune_system | 1.51389883 |
| 48 | MP0000490_abnormal_crypts_of | 1.50683515 |
| 49 | MP0008469_abnormal_protein_level | 1.45716876 |
| 50 | MP0003693_abnormal_embryo_hatching | 1.41387200 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.39684473 |
| 52 | MP0001873_stomach_inflammation | 1.38512079 |
| 53 | MP0003866_abnormal_defecation | 1.37320780 |
| 54 | MP0002139_abnormal_hepatobiliary_system | 1.37061861 |
| 55 | MP0002132_abnormal_respiratory_system | 1.34988712 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.34250930 |
| 57 | MP0003186_abnormal_redox_activity | 1.34049346 |
| 58 | MP0005085_abnormal_gallbladder_physiolo | 1.31029042 |
| 59 | MP0005451_abnormal_body_composition | 1.27858331 |
| 60 | MP0008260_abnormal_autophagy | 1.26695184 |
| 61 | MP0003656_abnormal_erythrocyte_physiolo | 1.25585316 |
| 62 | MP0002396_abnormal_hematopoietic_system | 1.24787936 |
| 63 | MP0009379_abnormal_foot_pigmentation | 1.18801628 |
| 64 | MP0009840_abnormal_foam_cell | 1.14676986 |
| 65 | MP0002933_joint_inflammation | 1.14009896 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.12276668 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.03519822 |
| 68 | MP0003075_altered_response_to | 1.03413222 |
| 69 | MP0002254_reproductive_system_inflammat | 1.03395644 |
| 70 | MP0004808_abnormal_hematopoietic_stem | 1.02695582 |
| 71 | MP0005365_abnormal_bile_salt | 1.02108698 |
| 72 | MP0000465_gastrointestinal_hemorrhage | 1.01994526 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 0.99669277 |
| 74 | MP0003566_abnormal_cell_adhesion | 0.98296534 |
| 75 | MP0001666_abnormal_nutrient_absorption | 0.97907459 |
| 76 | MP0002019_abnormal_tumor_incidence | 0.93862470 |
| 77 | MP0005390_skeleton_phenotype | 0.93614716 |
| 78 | MP0002998_abnormal_bone_remodeling | 0.92203999 |
| 79 | MP0004264_abnormal_extraembryonic_tissu | 0.91992608 |
| 80 | MP0004019_abnormal_vitamin_homeostasis | 0.91985515 |
| 81 | MP0005166_decreased_susceptibility_to | 0.91724270 |
| 82 | MP0009643_abnormal_urine_homeostasis | 0.90855241 |
| 83 | MP0002163_abnormal_gland_morphology | 0.90577396 |
| 84 | MP0001986_abnormal_taste_sensitivity | 0.89853494 |
| 85 | MP0004782_abnormal_surfactant_physiolog | 0.89524780 |
| 86 | MP0008057_abnormal_DNA_replication | 0.88796670 |
| 87 | MP0004147_increased_porphyrin_level | 0.88438792 |
| 88 | MP0005319_abnormal_enzyme/_coenzyme | 0.88412332 |
| 89 | MP0003828_pulmonary_edema | 0.88054612 |
| 90 | MP0000703_abnormal_thymus_morphology | 0.86562668 |
| 91 | MP0005174_abnormal_tail_pigmentation | 0.86041509 |
| 92 | MP0003172_abnormal_lysosome_physiology | 0.85874551 |
| 93 | MP0001348_abnormal_lacrimal_gland | 0.84713240 |
| 94 | MP0010307_abnormal_tumor_latency | 0.84543495 |
| 95 | MP0001542_abnormal_bone_strength | 0.84202453 |
| 96 | MP0008004_abnormal_stomach_pH | 0.84048269 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.83111862 |
| 98 | MP0005023_abnormal_wound_healing | 0.83099098 |
| 99 | MP0006036_abnormal_mitochondrial_physio | 0.82927787 |
| 100 | MP0003183_abnormal_peptide_metabolism | 0.80848290 |
| 101 | MP0000609_abnormal_liver_physiology | 0.79333021 |
| 102 | MP0005636_abnormal_mineral_homeostasis | 0.78546510 |
| 103 | MP0001765_abnormal_ion_homeostasis | 0.77804899 |
| 104 | MP0002877_abnormal_melanocyte_morpholog | 0.77665709 |
| 105 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74545192 |
| 106 | MP0005381_digestive/alimentary_phenotyp | 0.71317750 |
| 107 | MP0003300_gastrointestinal_ulcer | 0.69331006 |
| 108 | MP0002009_preneoplasia | 0.69285333 |
| 109 | MP0003252_abnormal_bile_duct | 0.68945533 |
| 110 | MP0005075_abnormal_melanosome_morpholog | 0.66794344 |
| 111 | MP0005083_abnormal_biliary_tract | 0.66024937 |
| 112 | MP0005164_abnormal_response_to | 0.64509617 |
| 113 | MP0010234_abnormal_vibrissa_follicle | 0.64110134 |
| 114 | MP0005076_abnormal_cell_differentiation | 0.63823966 |
| 115 | MP0000604_amyloidosis | 0.63503850 |
| 116 | MP0005165_increased_susceptibility_to | 0.62783386 |
| 117 | MP0004957_abnormal_blastocyst_morpholog | 0.62572818 |
| 118 | MP0009763_increased_sensitivity_to | 0.61783217 |
| 119 | MP0001663_abnormal_digestive_system | 0.60651212 |
| 120 | MP0002136_abnormal_kidney_physiology | 0.60024173 |
| 121 | MP0003786_premature_aging | 0.60011974 |
| 122 | MP0001851_eye_inflammation | 0.59876878 |
| 123 | MP0001764_abnormal_homeostasis | 0.59357839 |
| 124 | MP0000249_abnormal_blood_vessel | 0.57398950 |
| 125 | MP0000371_diluted_coat_color | 0.57055241 |
| 126 | MP0000477_abnormal_intestine_morphology | 0.55683989 |
| 127 | MP0000313_abnormal_cell_death | 0.54912720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.35767061 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.10924291 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.50476305 |
| 4 | Pustule (HP:0200039) | 5.10642980 |
| 5 | Increased IgM level (HP:0003496) | 4.59096259 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.43264591 |
| 7 | Myositis (HP:0100614) | 4.35785390 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.27781646 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.20419921 |
| 10 | Vacuolated lymphocytes (HP:0001922) | 4.09201303 |
| 11 | Autoimmune thrombocytopenia (HP:0001973) | 4.08074693 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.89096448 |
| 13 | Orchitis (HP:0100796) | 3.70445806 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 3.70086804 |
| 15 | Obstructive lung disease (HP:0006536) | 3.70086804 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.65282291 |
| 17 | Petechiae (HP:0000967) | 3.55154995 |
| 18 | Optic neuritis (HP:0100653) | 3.40581218 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.40581218 |
| 20 | Recurrent skin infections (HP:0001581) | 3.36810111 |
| 21 | Gingivitis (HP:0000230) | 3.26017017 |
| 22 | Stomatitis (HP:0010280) | 3.20833434 |
| 23 | Vasculitis (HP:0002633) | 3.14873123 |
| 24 | Chronic diarrhea (HP:0002028) | 3.10680280 |
| 25 | Agammaglobulinemia (HP:0004432) | 3.02197479 |
| 26 | Interstitial pulmonary disease (HP:0006530) | 2.88859526 |
| 27 | Hypergammaglobulinemia (HP:0010702) | 2.85510165 |
| 28 | Aplastic anemia (HP:0001915) | 2.84590463 |
| 29 | Urticaria (HP:0001025) | 2.75511570 |
| 30 | Meningitis (HP:0001287) | 2.74963277 |
| 31 | Systemic lupus erythematosus (HP:0002725) | 2.74387064 |
| 32 | Dysostosis multiplex (HP:0000943) | 2.72558285 |
| 33 | Spontaneous hematomas (HP:0007420) | 2.72109827 |
| 34 | Cellulitis (HP:0100658) | 2.69667582 |
| 35 | Abnormality of T cell physiology (HP:0011840) | 2.67578551 |
| 36 | IgM deficiency (HP:0002850) | 2.66887381 |
| 37 | Cheilitis (HP:0100825) | 2.65448016 |
| 38 | IgG deficiency (HP:0004315) | 2.61222962 |
| 39 | Poor head control (HP:0002421) | 2.59527376 |
| 40 | Panhypogammaglobulinemia (HP:0003139) | 2.59334358 |
| 41 | Recurrent viral infections (HP:0004429) | 2.57971763 |
| 42 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.55127426 |
| 43 | Abnormality of T cells (HP:0002843) | 2.53746909 |
| 44 | Anorexia (HP:0002039) | 2.52509702 |
| 45 | Hepatosplenomegaly (HP:0001433) | 2.50685248 |
| 46 | IgA deficiency (HP:0002720) | 2.48712029 |
| 47 | Malnutrition (HP:0004395) | 2.46848750 |
| 48 | Vertebral compression fractures (HP:0002953) | 2.46171343 |
| 49 | Leukocytosis (HP:0001974) | 2.45134728 |
| 50 | Recurrent cutaneous fungal infections (HP:0011370) | 2.43996774 |
| 51 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.43996774 |
| 52 | Prostate neoplasm (HP:0100787) | 2.42375671 |
| 53 | Abnormality of T cell number (HP:0011839) | 2.41027039 |
| 54 | Basal ganglia calcification (HP:0002135) | 2.40866963 |
| 55 | Increased cerebral lipofuscin (HP:0011813) | 2.40156207 |
| 56 | Increased serum ferritin (HP:0003281) | 2.39605360 |
| 57 | Chronic otitis media (HP:0000389) | 2.38543273 |
| 58 | Skin rash (HP:0000988) | 2.37102445 |
| 59 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.30277532 |
| 60 | Purpura (HP:0000979) | 2.29955647 |
| 61 | Inflammation of the large intestine (HP:0002037) | 2.29832172 |
| 62 | Periodontitis (HP:0000704) | 2.28974744 |
| 63 | Gastrointestinal inflammation (HP:0004386) | 2.28927414 |
| 64 | Recurrent bronchitis (HP:0002837) | 2.27404388 |
| 65 | Mucopolysacchariduria (HP:0008155) | 2.25651591 |
| 66 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.25651591 |
| 67 | Abnormality of the nasal mucosa (HP:0000433) | 2.25545763 |
| 68 | Chest pain (HP:0100749) | 2.25455938 |
| 69 | Recurrent pneumonia (HP:0006532) | 2.24951538 |
| 70 | Recurrent lower respiratory tract infections (HP:0002783) | 2.24796091 |
| 71 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.22491009 |
| 72 | Hemoptysis (HP:0002105) | 2.21645825 |
| 73 | Pulmonary infiltrates (HP:0002113) | 2.21361760 |
| 74 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.19057752 |
| 75 | Abnormality of iron homeostasis (HP:0011031) | 2.18533749 |
| 76 | Thrombocytosis (HP:0001894) | 2.18514237 |
| 77 | Abnormality of B cell number (HP:0010975) | 2.17385094 |
| 78 | Joint swelling (HP:0001386) | 2.17124062 |
| 79 | Gastrointestinal infarctions (HP:0005244) | 2.17021349 |
| 80 | Arterial thrombosis (HP:0004420) | 2.14635116 |
| 81 | Encephalitis (HP:0002383) | 2.12063771 |
| 82 | Nasal polyposis (HP:0100582) | 2.11584793 |
| 83 | Skin ulcer (HP:0200042) | 2.10569742 |
| 84 | Osteomyelitis (HP:0002754) | 2.09534588 |
| 85 | Increased IgE level (HP:0003212) | 2.07595315 |
| 86 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07249030 |
| 87 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07249030 |
| 88 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07249030 |
| 89 | T lymphocytopenia (HP:0005403) | 2.06573835 |
| 90 | Abnormality of glycolipid metabolism (HP:0010969) | 2.05391987 |
| 91 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.05391987 |
| 92 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.05391987 |
| 93 | Abnormality of eosinophils (HP:0001879) | 2.04620406 |
| 94 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.04334103 |
| 95 | Eosinophilia (HP:0001880) | 2.02484837 |
| 96 | Exertional dyspnea (HP:0002875) | 2.02481681 |
| 97 | Tongue fasciculations (HP:0001308) | 2.02467569 |
| 98 | Hypertensive crisis (HP:0100735) | 2.02400046 |
| 99 | Keratoconjunctivitis sicca (HP:0001097) | 2.00764215 |
| 100 | Loss of speech (HP:0002371) | 2.00689723 |
| 101 | Combined immunodeficiency (HP:0005387) | 2.00028714 |
| 102 | Prolonged bleeding time (HP:0003010) | 1.99414478 |
| 103 | Hypochromic anemia (HP:0001931) | 1.98948249 |
| 104 | Poikiloderma (HP:0001029) | 1.98158514 |
| 105 | Lymphopenia (HP:0001888) | 1.96828836 |
| 106 | Epistaxis (HP:0000421) | 1.96551561 |
| 107 | Colitis (HP:0002583) | 1.96537490 |
| 108 | Polycythemia (HP:0001901) | 1.95933541 |
| 109 | Alopecia of scalp (HP:0002293) | 1.95383374 |
| 110 | Abnormality of the prostate (HP:0008775) | 1.94955693 |
| 111 | Axonal loss (HP:0003447) | 1.92355984 |
| 112 | Sepsis (HP:0100806) | 1.92157757 |
| 113 | Granulocytopenia (HP:0001913) | 1.91144307 |
| 114 | Abnormality of the pleura (HP:0002103) | 1.90003275 |
| 115 | Autoimmune hemolytic anemia (HP:0001890) | 1.89479305 |
| 116 | Gastrointestinal stroma tumor (HP:0100723) | 1.89353564 |
| 117 | Gingival bleeding (HP:0000225) | 1.89288900 |
| 118 | Gangrene (HP:0100758) | 1.89249084 |
| 119 | Episodic fever (HP:0001954) | 1.88964478 |
| 120 | Keratoconjunctivitis (HP:0001096) | 1.88282351 |
| 121 | Abnormality of male internal genitalia (HP:0000022) | 1.85977408 |
| 122 | Nausea (HP:0002018) | 1.85501031 |
| 123 | Ileus (HP:0002595) | 1.84729774 |
| 124 | Severe combined immunodeficiency (HP:0004430) | 1.84689296 |
| 125 | Acute hepatic failure (HP:0006554) | 1.84591042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIM2 | 3.88132558 |
| 2 | BLK | 3.46251212 |
| 3 | MAP4K1 | 3.18096097 |
| 4 | MAP3K14 | 3.02178043 |
| 5 | TBK1 | 2.82576307 |
| 6 | IRAK4 | 2.76805577 |
| 7 | TXK | 2.75330904 |
| 8 | IRAK3 | 2.35984785 |
| 9 | NME2 | 2.30144725 |
| 10 | RIPK4 | 2.29583906 |
| 11 | ZAP70 | 2.22919012 |
| 12 | MAP3K12 | 2.21609009 |
| 13 | IKBKB | 2.02314551 |
| 14 | VRK2 | 2.01779749 |
| 15 | IKBKE | 2.01076516 |
| 16 | TYK2 | 2.00201978 |
| 17 | JAK3 | 1.97103412 |
| 18 | MAP3K11 | 1.97087804 |
| 19 | MATK | 1.96308902 |
| 20 | FES | 1.95698854 |
| 21 | CSK | 1.94482621 |
| 22 | MST4 | 1.89921251 |
| 23 | PIM1 | 1.78683640 |
| 24 | ERN1 | 1.74490445 |
| 25 | TEC | 1.69588940 |
| 26 | STK10 | 1.60221848 |
| 27 | TESK2 | 1.59535576 |
| 28 | TESK1 | 1.55659886 |
| 29 | BTK | 1.46340725 |
| 30 | KIT | 1.39511883 |
| 31 | ARAF | 1.36930134 |
| 32 | TNK2 | 1.33559195 |
| 33 | TRPM7 | 1.33235141 |
| 34 | BCKDK | 1.32035563 |
| 35 | SYK | 1.23827931 |
| 36 | CHUK | 1.20025835 |
| 37 | RPS6KA4 | 1.18701681 |
| 38 | TAOK3 | 1.16412618 |
| 39 | PBK | 1.12319189 |
| 40 | EIF2AK1 | 1.11119283 |
| 41 | NEK9 | 1.10484159 |
| 42 | PRPF4B | 1.09359763 |
| 43 | LYN | 1.09298995 |
| 44 | SIK3 | 1.07704060 |
| 45 | FGR | 1.07157839 |
| 46 | JAK1 | 1.07153327 |
| 47 | KDR | 1.05978557 |
| 48 | MAP2K3 | 1.01191517 |
| 49 | BMX | 0.99184368 |
| 50 | TAOK2 | 0.96908859 |
| 51 | LCK | 0.96606511 |
| 52 | ACVR1B | 0.96208642 |
| 53 | SMG1 | 0.95072269 |
| 54 | MARK3 | 0.94511864 |
| 55 | SCYL2 | 0.91574389 |
| 56 | PRKCQ | 0.90268852 |
| 57 | STK16 | 0.88558794 |
| 58 | ITK | 0.85329938 |
| 59 | PASK | 0.85054316 |
| 60 | STK24 | 0.83742657 |
| 61 | EPHB1 | 0.83443487 |
| 62 | LRRK2 | 0.83350954 |
| 63 | HCK | 0.80587454 |
| 64 | YES1 | 0.79496876 |
| 65 | MAPKAPK2 | 0.78603295 |
| 66 | PDK2 | 0.77085599 |
| 67 | MYLK | 0.74762198 |
| 68 | BUB1 | 0.74166585 |
| 69 | ABL2 | 0.73656513 |
| 70 | PRKG2 | 0.71802567 |
| 71 | EIF2AK3 | 0.70023638 |
| 72 | MAP3K3 | 0.68523700 |
| 73 | CDK19 | 0.67771165 |
| 74 | LIMK1 | 0.67510704 |
| 75 | RPS6KA6 | 0.66397253 |
| 76 | FGFR4 | 0.65924978 |
| 77 | PRKCD | 0.64218999 |
| 78 | TGFBR2 | 0.63001010 |
| 79 | JAK2 | 0.62365833 |
| 80 | PDK1 | 0.61778745 |
| 81 | PTK6 | 0.61736292 |
| 82 | GRK7 | 0.61224496 |
| 83 | NLK | 0.60900503 |
| 84 | EPHA3 | 0.60135751 |
| 85 | GRK6 | 0.56728237 |
| 86 | CSF1R | 0.56332397 |
| 87 | RPS6KL1 | 0.56207159 |
| 88 | RPS6KC1 | 0.56207159 |
| 89 | MST1R | 0.55804582 |
| 90 | MAPKAPK3 | 0.52814196 |
| 91 | PDPK1 | 0.51159156 |
| 92 | PINK1 | 0.49559648 |
| 93 | EIF2AK2 | 0.47595113 |
| 94 | PLK4 | 0.46868900 |
| 95 | MAP2K6 | 0.45936954 |
| 96 | DYRK1B | 0.44892212 |
| 97 | ERBB3 | 0.44804219 |
| 98 | DAPK1 | 0.44325754 |
| 99 | MAP3K6 | 0.44149107 |
| 100 | PAK4 | 0.43953605 |
| 101 | BMPR2 | 0.43191498 |
| 102 | EPHA2 | 0.42942016 |
| 103 | FGFR3 | 0.42854223 |
| 104 | FYN | 0.42687347 |
| 105 | PAK1 | 0.42632545 |
| 106 | RPS6KB2 | 0.42449994 |
| 107 | STK4 | 0.41229915 |
| 108 | CDK6 | 0.39362520 |
| 109 | ILK | 0.39189638 |
| 110 | MAPK15 | 0.38932474 |
| 111 | OXSR1 | 0.38544338 |
| 112 | MAP2K2 | 0.38324269 |
| 113 | ABL1 | 0.37514310 |
| 114 | CDK7 | 0.34413844 |
| 115 | MAP3K8 | 0.33612230 |
| 116 | MAPK11 | 0.33149908 |
| 117 | IRAK1 | 0.31565139 |
| 118 | ALK | 0.31234730 |
| 119 | GRK5 | 0.29922340 |
| 120 | TLK1 | 0.29611349 |
| 121 | DDR2 | 0.29500265 |
| 122 | TAOK1 | 0.29333194 |
| 123 | TRIB3 | 0.29259865 |
| 124 | MAP3K13 | 0.28961605 |
| 125 | MAP3K1 | 0.28954836 |
| 126 | NUAK1 | 0.28353083 |
| 127 | CLK1 | 0.28144265 |
| 128 | CDK4 | 0.26954573 |
| 129 | KSR2 | 0.26590405 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.84232469 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.78737985 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.76196896 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.66966857 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.54442508 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.43530364 |
| 7 | Legionellosis_Homo sapiens_hsa05134 | 2.19053005 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.15915247 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.13178367 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.03258769 |
| 11 | Measles_Homo sapiens_hsa05162 | 2.01999804 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.98164674 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.97816394 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.94305099 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.90189910 |
| 16 | Asthma_Homo sapiens_hsa05310 | 1.89174833 |
| 17 | Shigellosis_Homo sapiens_hsa05131 | 1.85910525 |
| 18 | Pertussis_Homo sapiens_hsa05133 | 1.75373886 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.73026454 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.71541232 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.69642417 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.66489117 |
| 23 | Salmonella infection_Homo sapiens_hsa05132 | 1.54316577 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.54131678 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.51101176 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.49048055 |
| 27 | Malaria_Homo sapiens_hsa05144 | 1.48727870 |
| 28 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.45180233 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.44414473 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.43298832 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40641501 |
| 32 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.40504544 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.40066964 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.39930179 |
| 35 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.34119212 |
| 36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.32260628 |
| 37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.30187930 |
| 38 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.29202822 |
| 39 | Base excision repair_Homo sapiens_hsa03410 | 1.27496250 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 1.25690511 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.25110681 |
| 42 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.22701917 |
| 43 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.21524360 |
| 44 | RNA polymerase_Homo sapiens_hsa03020 | 1.18408694 |
| 45 | Ribosome_Homo sapiens_hsa03010 | 1.14690494 |
| 46 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.13343280 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.13184915 |
| 48 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.12711691 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.11646619 |
| 50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.09986973 |
| 51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09970421 |
| 52 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.09460555 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07460625 |
| 54 | Hepatitis B_Homo sapiens_hsa05161 | 1.07458490 |
| 55 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.00636025 |
| 56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.99284872 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.98287866 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.97457559 |
| 59 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.95267071 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89906984 |
| 61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.89448440 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88576318 |
| 63 | Parkinsons disease_Homo sapiens_hsa05012 | 0.86826009 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85922686 |
| 65 | DNA replication_Homo sapiens_hsa03030 | 0.85831997 |
| 66 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.85742348 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84546495 |
| 68 | Mismatch repair_Homo sapiens_hsa03430 | 0.83184796 |
| 69 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.82159913 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81248337 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80055978 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.79553188 |
| 73 | Hepatitis C_Homo sapiens_hsa05160 | 0.79430821 |
| 74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.76627099 |
| 75 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.76418336 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72770487 |
| 77 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.71857854 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68711133 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63799806 |
| 80 | Homologous recombination_Homo sapiens_hsa03440 | 0.63065698 |
| 81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62024966 |
| 82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.60428748 |
| 83 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.59366848 |
| 84 | Mineral absorption_Homo sapiens_hsa04978 | 0.58193761 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56039394 |
| 86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55990369 |
| 87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55603219 |
| 88 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52269828 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51886588 |
| 90 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.49427750 |
| 91 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.49124160 |
| 92 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47792803 |
| 93 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47718520 |
| 94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47138963 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46885825 |
| 96 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45811091 |
| 97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45592576 |
| 98 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.43812688 |
| 99 | Platelet activation_Homo sapiens_hsa04611 | 0.40792258 |
| 100 | Huntingtons disease_Homo sapiens_hsa05016 | 0.39076432 |
| 101 | Peroxisome_Homo sapiens_hsa04146 | 0.38865424 |
| 102 | Amoebiasis_Homo sapiens_hsa05146 | 0.37778096 |
| 103 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.37632839 |
| 104 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37387882 |
| 105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.36922129 |
| 106 | Alzheimers disease_Homo sapiens_hsa05010 | 0.36782764 |
| 107 | Cell cycle_Homo sapiens_hsa04110 | 0.35537262 |
| 108 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34512264 |
| 109 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.34228972 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.34176009 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33704520 |
| 112 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.32325492 |
| 113 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.31773264 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.31130768 |
| 115 | HTLV-I infection_Homo sapiens_hsa05166 | 0.29967290 |
| 116 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.29757196 |
| 117 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.29394611 |
| 118 | Basal transcription factors_Homo sapiens_hsa03022 | 0.29377487 |

